share_log

B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63

Benzinga ·  Nov 17, 2023 08:12

B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and announces Price Target of $63.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment